Acutaas Chemicals Limited — Investor Meet, 06-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Acutaas Chemicals reported robust Q4 FY26 results: revenue up 40.3% YoY to INR 432.8 Cr, EBITDA 42.4%, and PAT up 114.1% to INR 134.3 Cr. FY26 saw revenue of INR 1,339.4 Cr, EBITDA INR 480.4 Cr, and PAT INR 356.4 Cr. Management guides for 25% revenue growth and similar EBITDA margins in FY27. Key drivers include a strong CDMO pipeline (4 new validated products with INR 50-100 Cr peak potential each), advancing battery chemical business (first two products commercialized, two more by FY27), and semiconductor expansion via Indichem JV (plant completion H2 CY26). The company is boosting R&D and moving towards higher-value products for diversified growth. Outlook is confident.